1. Home
  2. MBIO vs UGRO Comparison

MBIO vs UGRO Comparison

Compare MBIO & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIO

Mustang Bio Inc.

N/A

Current Price

$0.87

Market Cap

7.0M

Sector

Health Care

ML Signal

N/A

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$2.38

Market Cap

1.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIO
UGRO
Founded
2015
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.0M
1.8M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
MBIO
UGRO
Price
$0.87
$2.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.1K
76.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$40,008,850.00
Revenue This Year
N/A
$98.41
Revenue Next Year
N/A
$23.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.11
52 Week High
$7.00
$4.50

Technical Indicators

Market Signals
Indicator
MBIO
UGRO
Relative Strength Index (RSI) 37.61 51.10
Support Level $0.53 $2.12
Resistance Level $1.00 $4.50
Average True Range (ATR) 0.07 0.29
MACD -0.01 -0.10
Stochastic Oscillator 3.21 12.40

Price Performance

Historical Comparison
MBIO
UGRO

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

Share on Social Networks: